Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Aptevo Therapeutics Inc APVO

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for rational design of precision immune modulatory drugs. Its lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:APVO)

No current opinion is available.

Bullboard Posts (NDAQ:APVO)

APVO.....come on down!!!!!!!!!!!

Let this drop like a rock ; )
Iseneschal - 11 days ago

APVO....N.L.O.D.....LoL

Sub 70 ? Probably
Iseneschal - 11 days ago

RE:Why Aptevo Therapeutics Stock Is Cratering | Benzinga

I'd say The Maggot has to change the way he does RS's......people start to catch on to the way Mr. M works. Surprise the masses....
Iseneschal - April 12, 2024

Why Aptevo Therapeutics Stock Is Cratering | Benzinga

News; $APVO Why Aptevo Therapeutics Stock Is Cratering | BenzingaAptevo Therapeutics Inc. (NASDAQ:APVO) shares are trading lower...
whytestocks - April 11, 2024

APVO....big meltdownsince my last post....

I knew that there was to be a financing sooner or later....just didn't figure on a P.O at $1.35 I'd call that $ raise exercise ....
Iseneschal - April 11, 2024

APVO....NR this a.m

Aptevo Therapeutics Provides Pipeline Update 2024-04-10 06:04 ET - News Release   Breast cancer patient who improved from...
Iseneschal - April 10, 2024